A detailed history of Kbc Group Nv transactions in Penumbra Inc stock. As of the latest transaction made, Kbc Group Nv holds 1,018 shares of PEN stock, worth $249,247. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,018
Previous 891 14.25%
Holding current value
$249,247
Previous $160,000 23.75%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$163.64 - $210.12 $20,782 - $26,685
127 Added 14.25%
1,018 $198,000
Q2 2024

Jul 17, 2024

BUY
$172.27 - $223.95 $18,605 - $24,186
108 Added 13.79%
891 $160,000
Q1 2024

May 08, 2024

BUY
$220.09 - $273.15 $18,927 - $23,490
86 Added 12.34%
783 $175,000
Q4 2023

Feb 13, 2024

BUY
$181.44 - $260.22 $126,463 - $181,373
697 New
697 $175,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.28B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.